BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 11925560)

  • 1. Biotechnology patents: strategies for meeting economic and ethical concerns.
    Gold ER
    Nat Genet; 2002 Apr; 30(4):359. PubMed ID: 11925560
    [No Abstract]   [Full Text] [Related]  

  • 2. Europe's patent rebellion.
    Wadman M
    Fortune; 2001 Oct; 144(6):44. PubMed ID: 11586878
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotechnology. Lawsuit challenges legal basis for patenting human genes.
    Marshall E
    Science; 2009 May; 324(5930):1000-1. PubMed ID: 19460975
    [No Abstract]   [Full Text] [Related]  

  • 4. Equivalents in biotechnology patents.
    Auer HE
    Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574
    [No Abstract]   [Full Text] [Related]  

  • 5. The gene patenting controversy: a convergence of law, economic interests, and ethics.
    Kevles DJ; Berkowitz A
    Brooklyn Law Rev; 2001; 67(1):233-48. PubMed ID: 12645549
    [No Abstract]   [Full Text] [Related]  

  • 6. Ruling on BRCA gene patents could have limited impact.
    Goozner M
    J Natl Cancer Inst; 2010 Jun; 102(11):754-7. PubMed ID: 20498427
    [No Abstract]   [Full Text] [Related]  

  • 7. US Supreme Court decision could compromise biotech patents.
    Robertson D
    Nat Biotechnol; 2001 May; 19(5):394. PubMed ID: 11328981
    [No Abstract]   [Full Text] [Related]  

  • 8. Biomedical patents and ethics: a Canadian solution.
    Gold ER
    McGill Law J; 2000 May; 45(2):413-35. PubMed ID: 12688288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European patents. Tough stance on stem cell, DNA claims.
    Vogel G
    Science; 2002 Aug; 297(5582):754-5. PubMed ID: 12161624
    [No Abstract]   [Full Text] [Related]  

  • 10. French researchers take a stand against cancer gene patent.
    Butler D; Goodman S
    Nature; 2001 Sep; 413(6852):95-6. PubMed ID: 11557932
    [No Abstract]   [Full Text] [Related]  

  • 11. US Supreme Court applies strict limits to patents.
    Robertson D
    Nat Biotechnol; 2002 Jul; 20(7):639. PubMed ID: 12089532
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic patents: gatekeeper to the promised cures.
    Westin LP
    Thomas Jefferson Law Rev; 2002; 25(1):271-99. PubMed ID: 15164741
    [No Abstract]   [Full Text] [Related]  

  • 13. How many lawyers does it take...greed and legal wrangling could stifle the medical revolution.
    New Sci; 2002 May; 174(2343):3. PubMed ID: 12731531
    [No Abstract]   [Full Text] [Related]  

  • 14. It's all about cures and cash. How the winner of the race to patent human genes may strike it rich.
    Sherrid P
    US News World Rep; 2001 Jan; 130(1):35-6. PubMed ID: 11189705
    [No Abstract]   [Full Text] [Related]  

  • 15. Super-enzyme patents get their day in court.
    Cyranoski D
    Nature; 2002 Oct; 419(6909):767. PubMed ID: 12397315
    [No Abstract]   [Full Text] [Related]  

  • 16. US to rule on research patent.
    Ruttimann J
    Nature; 2006 Mar; 440(7084):587. PubMed ID: 16572133
    [No Abstract]   [Full Text] [Related]  

  • 17. Intellectual property. Supreme Court rules out patents on 'natural' genes.
    Marshall E
    Science; 2013 Jun; 340(6139):1387-8. PubMed ID: 23788772
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 19. The scope of utility in the twenty-first century: new guidance for gene-related patents.
    Summers TM
    Georgetown Law J; 2003 Jan; 91(2):475-509. PubMed ID: 15046071
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostics firms face new patent claim worries.
    Allison M
    Nat Biotechnol; 2009 Jul; 27(7):586-7. PubMed ID: 19587651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.